Heidi May
Intermountain Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Heidi May.
Journal of the American College of Cardiology | 2014
J. Brent Muhlestein; Heidi May; Deborah Winegar; Jeffrey Rollo; Margery Connelly; James Otvos; Jeffrey L. Anderson
GlycA and GlycB are novel nuclear magnetic resonance spectroscopy (NMR) signals in plasma arising from the glycosylation of circulating acute phase proteins, especially fibrinogen, a1-antichymotrypsin, haptoglobin-1, a1-antitrypsin, complement C3 and a1-acid glycoprotein. These acute phase proteins
Journal of the American College of Cardiology | 2013
Jeffrey Rollo; Stacey Knight; Heidi May; Jeffrey L. Anderson; J. Muhlestein; Thomas W. Bunch; John F. Carlquist
Genetic predisposition to dementia has been strongly sought, but risk loci remain elusive. Atrial fibrillation (AF), a known risk factor for cerebrovascular accidents (CVA), was recently linked with dementia, especially in a younger population. Two chromosomal loci, 4q25 and 16q22, are associated
Journal of the American College of Cardiology | 2017
J. Brent Muhlestein; Heidi May; Oxana Galenko; Kirk U. Knowlton; James Otvos; Margery Connelly; Donald L. Lappé; Jeffrey L. Anderson
Background: GlycA, a novel marker of inflammation, has been associated with future CV risk among patients with or without pre-existing coronary artery disease (CAD). Whether GlycA is an independent and additive predictor of high sensitivity C-reactive protein (HS-CRP) needs further study. Methods:
Journal of the American College of Cardiology | 2016
J. Brent Muhlestein; Heidi May; Deborah Winegar; Jeffrey Rollo; Margery Connelly; James Otvos; Jeffrey L. Anderson
HDL particle (HDL-P) concentrations are comprised of particles that vary in size and composition, and potentially, in risk prediction. Inflammation is known to modulate HDL function. Whether increased inflammation alters associations of HDL subclasses with CAD needs further study. Pts (N=2,848) of
Journal of the American College of Cardiology | 2013
Benjamin D. Horne; Jason Lappe; Abdallah G. Kfoury; Deborah Budge; R. Alharethi; Jeffrey L. Anderson; Kimberly D. Brunisholz; Joseph B. Muhlestein; Heidi May; Tami L. Bair; Donald L. Lappé
Innovative strategies and tools for stratification of 30-day readmission (30dR) risk are needed due to penalties legislated in the Affordable Care Act (ACA). The Intermountain Risk Score (IMRS) is a sex-specific tool derived to predict mortality using the complete blood count (CBC), basic metabolic
Journal of the American College of Cardiology | 2017
Benjamin D. Horne; T. Jared Bunch; Heidi May; Kirk U. Knowlton; Joseph B. Muhlestein; Kevin G. Graves; Victoria Jacobs; Donald L. Lappé
Background: Oral anticoagulation therapy (OAC) guidelines recommend using CHA2DS2-VASc to determine OAC need in atrial fibrillation (AF). A usable tool, CHA2DS2-VASc is challenged by its predictive ability. Based on complete blood count and basic metabolic profile, the Intermountain Mortality Risk
Journal of the American College of Cardiology | 2016
Boaz D. Rosen; Ravi Sharma; Kenneth Horton; Heidi May; Yitzhak Rosen; Jeffrey L. Anderson; Donald L. Lappé; Joao Lima; Joseph B. Muhlestein
Obesity is major health problem. Abdominal obesity is associated with the metabolic syndrome, coronary artery disease (CAD) and heart failure (HF). It is unclear if abdominal obesity is associated with left ventricular (LV) dysfunction independently of hypertension (HTN), CAD and weight among
Journal of the American College of Cardiology | 2016
Tami L. Bair; Heidi May; Viet T. Le; Donald L. Lappé; Jeffrey L. Anderson; J. Muhlestein
Low serum testosterone (T) is an independent risk factor for CV and total mortality. The impact of T therapy on CV outcomes, especially among older men with pre-existing severe CAD, is unknown. All men >50 yrs of age, with severe CAD (≥70% stenosis), a low (<212 ng/dL) baseline T level, 1 follow-
Journal of the American College of Cardiology | 2015
Viet T. Le; Stacey Knight; Heidi May; Tami L. Bair; Joseph B. Muhlestein; Donald L. Lappé; Joao Lima; Boaz D. Rosen; David M. Bluemke; Jeffrey L. Anderson
Coronary artery calcification (CAC) is pathognomonic for atherosclerosis and has been demonstrated to be associated with elevated risk of cardiovascular (CV) events. Diabetes (DM) is considered a “coronary equivalent” suggesting a risk of a first CV event comparable to that in those who have had
Journal of the American College of Cardiology | 2013
Tami L. Bair; Heidi May; Brigham Smith; Shadi Karabsheh; Qunyu P. Li; Anwar Tandar; Jeffrey L. Anderson; Donald L. Lappé; J. Muhlestein
Vitamin (Vit) D is a critical factor related to calcium (CA) absorption and metabolism, and Vit D levels are associated with serum CA levels, coronary artery disease (CAD) and major adverse CV events. Additionally, severity of coronary calcification has been used as a surrogate marker for CAD